Back
Matinas BioPharma Holdings Stock Price Chart
Sponsored
MTNB
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
38
MTNB
Matinas BioPharma Holdings
Last Price:
0.63
Seasonality Move:
10.6%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MTNB is experiencing slight buying pressure.
Matinas BioPharma Holdings Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.61 | Buy |
20-day SMA: | 0.93 | Sell |
50-day SMA: | 2.45 | Sell |
200-day SMA: | 0.89 | Sell |
8-day EMA: | 0.64 | Sell |
20-day EMA: | 1.09 | Sell |
50-day EMA: | 1.69 | Sell |
200-day EMA: | 1.18 | Sell |
Matinas BioPharma Holdings Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.54 | Sell |
Relative Strength Index (14 RSI): | 25.5 | Sell |
Chaikin Money Flow: | 22780 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.21 - 2.65) | Sell |
Bollinger Bands (100): | ( - 3.16) | Sell |
Matinas BioPharma Holdings Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Matinas BioPharma Holdings Stock
Is Matinas BioPharma Holdings Stock a Buy?
- Matinas BioPharma Holdings share price is 0.62 while MTNB 8-day simple moving average is 0.61, which is a Buy signal.
- The stock price of MTNB is 0.62 while Matinas BioPharma Holdings 20-day SMA is 0.93, which makes it a Sell.
- Matinas BioPharma Holdings 50-day simple moving average is 2.45 while MTNB share price is 0.62, making it a Sell technically.
- MTNB stock price is 0.62 and Matinas BioPharma Holdings 200-day simple moving average is 0.89, creating a Sell signal.
MTNB Technical Analysis vs Fundamental Analysis
Sell
38
Matinas BioPharma Holdings (MTNB)
is a Sell
Is Matinas BioPharma Holdings a Buy or a Sell?
-
Matinas BioPharma Holdings stock is rated a Sell
The current Matinas BioPharma Holdings [MTNB] share price is $0.62. The Score for MTNB is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
Matinas BioPharma Holdings Stock Info
Market Cap:
3.13M
Price in USD:
0.62
Share Volume:
115.88K
Matinas BioPharma Holdings 52-Week Range
52-Week High:
21.50
52-Week Low:
0.50
Sell
38
Matinas BioPharma Holdings (MTNB)
is a Sell
Matinas BioPharma Holdings Share Price Forecast
-
What is the Matinas BioPharma Holdings stock price today?
The Matinas BioPharma Holdings stock price is 0.62 USD today. -
Will MTNB stock go up or go down?
Matinas BioPharma Holdings> share price is forecast to RISE/FALL based on technical indicators -
Is Matinas BioPharma Holdings overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Matinas BioPharma Holdings is overvalued.
Is Matinas BioPharma Holdings Stock a Buy?
- Matinas BioPharma Holdings share price is 0.62 while MTNB 8-day exponential moving average is 0.64, which is a Sell signal.
- The stock price of MTNB is 0.62 while Matinas BioPharma Holdings 20-day EMA is 1.09, which makes it a Sell.
- Matinas BioPharma Holdings 50-day exponential moving average is 1.69 while MTNB share price is 0.62, making it a Sell technically.
- MTNB stock price is 0.62 and Matinas BioPharma Holdings 200-day simple moving average is 1.18, creating a Sell signal.
Fundamental Analysis of Matinas BioPharma Holdings
Is Matinas BioPharma Holdings a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.44 per share, and an increase next year of $1.06 per share.
Technical Analysis of Matinas BioPharma Holdings
Should I short Matinas BioPharma Holdings stock?
- MTNB Moving Average Covergence Divergence (MACD) indicator is -0.54, suggesting Matinas BioPharma Holdings is a Sell
- Matinas BioPharma Holdings Relative Strength Index (RSI) is 25.5, which suggest Matinas BioPharma Holdings is oversold
- The Bollinger Bands (25) for Matinas BioPharma Holdings is (0.21 - 2.65), which suggest Matinas BioPharma Holdings is a Sell
- The Bollinger Bands (100) for Matinas BioPharma Holdings is ( - 3.16), which suggest Matinas BioPharma Holdings is a Sell
* Matinas BioPharma Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.